世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

牛高山病の世界市場規模は、薬剤クラス別(牛高山病利尿剤、牛高山病抗生物質、牛高山病食欲増進剤、その他牛高山病)、流通チャネル別(牛高山病薬剤の動物病院経由の販売)、で調査、牛高山病の動物病院向け販売、牛高山病の動物薬店向け販売、牛高山病のその他流通チャネル向け販売)および地域別予測 2022-2028


Global Bovine High-Mountain Disease Market Size study, by Drug Class (Bovine High-Mountain Disease Diuretics, Bovine High-Mountain Disease Antibiotics, Bovine High-Mountain Disease Appetite Stimulators, Other Bovine High-Mountain Disease Drugs), by Distribution Channel (Bovine High-Mountain Disease Drugs Sales via Veterinary Hospitals, Bovine High-Mountain Disease Drugs Sales via Veterinary Clinics, Bovine High-Mountain Disease Drugs Sales via Veterinary Pharmaceutical Stores, Bovine High-Mountain Disease Drugs Sales via Other Distribution Channels) and Regional Forecasts 2022-2028

世界の牛高山病市場は、2021年に約41億米ドルと評価され、予測期間2022-2028年には5.25%以上の健全な成長率で成長すると予測されています。牛高山病(BHMD)は、一般にブリスクレット病として知られており、多く... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Bizwit Research & Consulting LLP
ビズウィットリサーチ&コンサルティング
2022年5月6日 US$4,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
200 英語

 

サマリー

世界の牛高山病市場は、2021年に約41億米ドルと評価され、予測期間2022-2028年には5.25%以上の健全な成長率で成長すると予測されています。牛高山病(BHMD)は、一般にブリスクレット病として知られており、多くの子牛を死に至らしめる深刻な病気です。右心不全は牛高山病の最も一般的な原因であり、高地での低酸素性肺高血圧を特徴とする。牛高山病は、標高7,000フィート以上の場所で、あらゆる年齢、品種の牛に発症する病気です。牛の呼吸器疾患の発生率は、標高に密接に比例する。高地、生理的、遺伝的、環境的な変数がすべて牛の高山病に関係しています。また、牛高山病は牛呼吸器病の死亡率や罹患率(BRD)との関連も指摘されています。衰弱、虚脱、下痢、目の膨張、むくみなどは、牛高山病と関連する症状の一部です。うっ血性心不全の発生率の上昇、呼吸器疾患の有病率の上昇、動物の遺伝的感受性、主要企業の認識と取り組みの高まりが、予測期間中、牛高山病の採用を後押ししています。インスタンスの場合Zoetis Inc.は、2021年3月に長期的な持続可能性目標を発表し、その内容は、動物ケアの向上を通じて地球と人類に栄養を与えるという会社の使命に基づいています。国連の持続可能な開発目標17項目のうち10項目への支援を含む、コミュニティ、動物、地球に対するZoetisの具体的なコミットメントが、Driven to Care(SDGs)の旗印の下に実現されています。また、治療に対する政府予算の増加や動物病院設立のための投資の増加は、牛高山病市場の全体的な成長を後押しする可能性が高いです。しかし、この病気に関する情報や知識の不足、治療費の高騰は、2022-2028年の予測期間中に市場の拡大を妨げる可能性があります。

世界の牛高山病市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、中南米、その他の地域です。北米は、世界的に主要な地域です。標高の高い地域の存在が、北米の市場成長を牽引しています。一方、アジア太平洋地域も、予測期間2022-2028年にかけて最も高い成長率を示すと予測されています。牛高山病の治療に対する政府投資の増加により、予測期間中に市場は成長すると予想されます。


本レポートに含まれる主な市場プレイヤーは以下の通りです:
Zoetis Inc.
バイエル社
イーライリリー・アンド・カンパニー
デクラ・ファーマシューティカルズ
Merck and Co.Inc.
ヒースローサイエンティフィック


本調査の目的は、近年における様々なセグメント&国の市場規模を定義し、今後8年間の値を予測することです。本レポートは、本調査の対象である各地域・国において、産業の質的・量的な側面を取り込むよう設計されています。さらに、市場の将来的な成長を規定する推進要因や課題など、重要な側面に関する詳細な情報も提供しています。さらに、本レポートでは、主要企業の競争環境と製品提供の詳細な分析とともに、関係者が投資するためのミクロ市場での利用可能な機会も組み込んでいます。市場の詳細なセグメントとサブセグメントを以下に説明する:



薬効分類別で見る
牛高山病の利尿剤
牛ハイマウンテンディジーズ 抗菌剤
牛の高山病食欲増進剤
その他の牛高山病治療薬

流通チャネル別
牛高山病治療薬の動物病院経由の販売について
牛高山病治療薬の動物病院経由での販売について
牛高山病治療薬の動物用医薬品販売店経由での販売について
その他の流通経路での牛高山病治療薬の販売について
地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
連邦王国
ドイツ
フランス
スペイン
イタリア
ROE

アジア太平洋
中国
インド
日本
オーストラリア
南朝鮮
ロアパック
ラテンアメリカ
ブラジル
メキシコ
その他の地域

さらに、本調査で考慮した年は以下の通りです:

歴史的年号-2018年、2019年、2020年
基準年 - 2021年
予測期間 - 2022年~2028年

市場調査における牛高山病の世界市場のターゲットオーディエンス:

主なコンサルティング会社・アドバイザーのご紹介
大企業・中堅企業・中小企業
ベンチャーキャピタル
付加価値再販業者(VAR)
サードパーティナレッジプロバイダー
投資銀行家
投資家の皆様へ


ページTOPに戻る


目次

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Bovine High-Mountain Disease Market, by Region, 2020-2028 (USD Billion)
1.2.2. Bovine High-Mountain Disease Market, by Drug Class, 2020-2028 (USD Billion)
1.2.3. Bovine High-Mountain Disease Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bovine High-Mountain Disease Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bovine High-Mountain Disease Market Dynamics
3.1. Bovine High-Mountain Disease Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of Congestive Heart Failure
3.1.1.2. Rising Prevalence of Respiratory Diseases
3.1.1.3. Genetic Susceptibility in Animals
3.1.1.4. Rising awareness and initiatives among key players
3.1.2. Market Challenges
3.1.2.1. Lack of Information and Knowledge about the disease
3.1.2.2. High Cost of the Treatment

3.1.3. Market Opportunities
3.1.3.1. Rise in Government funding for the treatment
3.1.3.2. Rising investment to set up Veterinary Hospital
Chapter 4. Global Bovine High-Mountain Disease Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Bovine High-Mountain Disease Market, by Drug Class
6.1. Market Snapshot
6.2. Global Bovine High-Mountain Disease Market by Drug Class, Performance – Potential Analysis
6.3. Global Bovine High-Mountain Disease Market Estimates & Forecasts by Drug Class, 2018-2028 (USD Billion)
6.4. Bovine High-Mountain Disease Market, Sub Segment Analysis
6.4.1 Bovine High-Mountain Disease Diuretics
6.4.2 Bovine High-Mountain Disease Antibiotics
6.4.3 Bovine High-Mountain Disease Appetite Stimulators
6.4.4 Other Bovine High-Mountain Disease Drugs

Chapter 7. Global Bovine High-Mountain Disease Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Bovine High-Mountain Disease Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Bovine High-Mountain Disease Market Estimates & Forecasts by Distribution Channel, 2018-2028 (USD Billion)
7.4. Bovine High-Mountain Disease Market, Sub Segment Analysis
7.4.1 Bovine High-Mountain Disease Drugs Sales via Veterinary Hospitals
7.4.2 Bovine High-Mountain Disease Drugs Sales via Veterinary Clinics
7.4.3 Bovine High-Mountain Disease Drugs Sales via Veterinary Pharmaceutical Stores
7.4.4 Bovine High-Mountain Disease Drugs Sales via Other Distribution Channels


Chapter 8. Global Bovine High-Mountain Disease Market, Regional Analysis
8.1. Bovine High-Mountain Disease Market, Regional Market Snapshot
8.2. North America Bovine High-Mountain Disease Market
8.2.1. U.S. Bovine High-Mountain Disease Market
8.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2028
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Bovine High-Mountain Disease Market
8.3. Europe Bovine High-Mountain Disease Market Snapshot
8.3.1. U.K. Bovine High-Mountain Disease Market
8.3.2. Germany Bovine High-Mountain Disease Market
8.3.3. France Bovine High-Mountain Disease Market
8.3.4. Spain Bovine High-Mountain Disease Market
8.3.5. Italy Bovine High-Mountain Disease Market
8.3.6. Rest of Europe Bovine High-Mountain Disease Market
8.4. Asia-Pacific Bovine High-Mountain Disease Market Snapshot
8.4.1. China Bovine High-Mountain Disease Market
8.4.2. India Bovine High-Mountain Disease Market
8.4.3. Japan Bovine High-Mountain Disease Market
8.4.4. Australia Bovine High-Mountain Disease Market
8.4.5. South Korea Bovine High-Mountain Disease Market
8.4.6. Rest of Asia Pacific Bovine High-Mountain Disease Market
8.5. Latin America Bovine High-Mountain Disease Market Snapshot
8.5.1. Brazil Bovine High-Mountain Disease Market
8.5.2. Mexico Bovine High-Mountain Disease Market
8.6. Rest of The World Bovine High-Mountain Disease Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Zoetis Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Bayer AG
9.2.3. Eli Lilly and Company
9.2.4. Dechra Pharmaceuticals
9.2.5. ,Merck and Co. Inc.
9.2.6. Heathrow Scientific
9.2.7.

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

 

ページTOPに戻る


 

Summary

Global Bovine High-Mountain Disease Market is valued at approximately USD 4.1 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.25 % over the forecast period 2022-2028. Bovine high-mountain disease (BHMD), commonly known as brisket disease, is a serious disease that kills a lot of calves. Right heart failure is the most common cause of bovine high-mountain illness, which is characterised by hypoxic pulmonary hypertension at high altitudes. Bovine high-mountain illness is a disease that affects cattle of all ages and breeds at elevations above 7,000 feet. The incidence rate of bovine respiratory illness is closely proportional to the elevation. High altitude, physiologic, genetic, and environmental variables are all linked to bovine high-mountain illness. It's also been suggested that bovine high-mountain disease is linked to bovine respiratory disease mortality and morbidity (BRD). Weakness, collapse, diarrhoea, bulging eyes, and swelling are some of the symptoms linked with bovine high-mountain sickness. Rising incidence of congestive heart failure, rising prevalence of respiratory diseases, genetic susceptibility in animals and rising awareness and initiatives among key players have driven the adoption of Bovine High-Mountain Disease across the projected period. For Instance: Zoetis Inc. unveiled its long-term sustainability goals in March 2021, which were based on the company's mission to nourish the earth and humanity through increasing animal care. Zoetis' specific commitments to Communities, Animals, and the Planet, including support for 10 of the 17 United Nations Sustainable Development Goals, are brought to life under the banner Driven to Care (SDGs). Also, rise in government funding for the treatment and rising investment to set up Veterinary Hospital is most likely to boost the overall growth of the Bovine High-Mountain Disease market. However, lack of information and knowledge about the disease and high cost of treatment can obstruct the market's expansion over the projection period of 2022-2028.

The key regions considered for the global Bovine High-Mountain Disease market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Presence of high elevation is driving the market growth in North America. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period 2022-2028. The market is expected to grow during the projected period, due rising government investment in the treatment of Bovine-high Mountain Disease.


Major market players included in this report are:
Zoetis Inc.
Bayer AG
Eli Lilly and Company
Dechra Pharmaceuticals
Merck and Co. Inc.
Heathrow Scientific


The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:



By Drug Class:
Bovine High-Mountain Disease Diuretics
Bovine High-Mountain Disease Antibiotics
Bovine High-Mountain Disease Appetite Stimulators
Other Bovine High-Mountain Disease Drugs

By Distribution Channel:
Bovine High-Mountain Disease Drugs Sales via Veterinary Hospitals
Bovine High-Mountain Disease Drugs Sales via Veterinary Clinics
Bovine High-Mountain Disease Drugs Sales via Veterinary Pharmaceutical Stores
Bovine High-Mountain Disease Drugs Sales via Other Distribution Channels
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Bovine High-Mountain Disease Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors



ページTOPに戻る


Table of Contents

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Bovine High-Mountain Disease Market, by Region, 2020-2028 (USD Billion)
1.2.2. Bovine High-Mountain Disease Market, by Drug Class, 2020-2028 (USD Billion)
1.2.3. Bovine High-Mountain Disease Market, by Distribution Channel, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Bovine High-Mountain Disease Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Bovine High-Mountain Disease Market Dynamics
3.1. Bovine High-Mountain Disease Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising incidence of Congestive Heart Failure
3.1.1.2. Rising Prevalence of Respiratory Diseases
3.1.1.3. Genetic Susceptibility in Animals
3.1.1.4. Rising awareness and initiatives among key players
3.1.2. Market Challenges
3.1.2.1. Lack of Information and Knowledge about the disease
3.1.2.2. High Cost of the Treatment

3.1.3. Market Opportunities
3.1.3.1. Rise in Government funding for the treatment
3.1.3.2. Rising investment to set up Veterinary Hospital
Chapter 4. Global Bovine High-Mountain Disease Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Bovine High-Mountain Disease Market, by Drug Class
6.1. Market Snapshot
6.2. Global Bovine High-Mountain Disease Market by Drug Class, Performance – Potential Analysis
6.3. Global Bovine High-Mountain Disease Market Estimates & Forecasts by Drug Class, 2018-2028 (USD Billion)
6.4. Bovine High-Mountain Disease Market, Sub Segment Analysis
6.4.1 Bovine High-Mountain Disease Diuretics
6.4.2 Bovine High-Mountain Disease Antibiotics
6.4.3 Bovine High-Mountain Disease Appetite Stimulators
6.4.4 Other Bovine High-Mountain Disease Drugs

Chapter 7. Global Bovine High-Mountain Disease Market, by Distribution Channel
7.1. Market Snapshot
7.2. Global Bovine High-Mountain Disease Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Bovine High-Mountain Disease Market Estimates & Forecasts by Distribution Channel, 2018-2028 (USD Billion)
7.4. Bovine High-Mountain Disease Market, Sub Segment Analysis
7.4.1 Bovine High-Mountain Disease Drugs Sales via Veterinary Hospitals
7.4.2 Bovine High-Mountain Disease Drugs Sales via Veterinary Clinics
7.4.3 Bovine High-Mountain Disease Drugs Sales via Veterinary Pharmaceutical Stores
7.4.4 Bovine High-Mountain Disease Drugs Sales via Other Distribution Channels


Chapter 8. Global Bovine High-Mountain Disease Market, Regional Analysis
8.1. Bovine High-Mountain Disease Market, Regional Market Snapshot
8.2. North America Bovine High-Mountain Disease Market
8.2.1. U.S. Bovine High-Mountain Disease Market
8.2.1.1. Drug Class breakdown estimates & forecasts, 2018-2028
8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2018-2028
8.2.2. Canada Bovine High-Mountain Disease Market
8.3. Europe Bovine High-Mountain Disease Market Snapshot
8.3.1. U.K. Bovine High-Mountain Disease Market
8.3.2. Germany Bovine High-Mountain Disease Market
8.3.3. France Bovine High-Mountain Disease Market
8.3.4. Spain Bovine High-Mountain Disease Market
8.3.5. Italy Bovine High-Mountain Disease Market
8.3.6. Rest of Europe Bovine High-Mountain Disease Market
8.4. Asia-Pacific Bovine High-Mountain Disease Market Snapshot
8.4.1. China Bovine High-Mountain Disease Market
8.4.2. India Bovine High-Mountain Disease Market
8.4.3. Japan Bovine High-Mountain Disease Market
8.4.4. Australia Bovine High-Mountain Disease Market
8.4.5. South Korea Bovine High-Mountain Disease Market
8.4.6. Rest of Asia Pacific Bovine High-Mountain Disease Market
8.5. Latin America Bovine High-Mountain Disease Market Snapshot
8.5.1. Brazil Bovine High-Mountain Disease Market
8.5.2. Mexico Bovine High-Mountain Disease Market
8.6. Rest of The World Bovine High-Mountain Disease Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Zoetis Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Bayer AG
9.2.3. Eli Lilly and Company
9.2.4. Dechra Pharmaceuticals
9.2.5. ,Merck and Co. Inc.
9.2.6. Heathrow Scientific
9.2.7.

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(農業・林業)の最新刊レポート

Bizwit Research & Consulting LLP社の農業・家畜分野での最新刊レポート

本レポートと同じKEY WORD(clinics)の最新刊レポート


よくあるご質問


Bizwit Research & Consulting LLP社はどのような調査会社ですか?


Bizwit Research & Consulting (Bizwit Research & Consulting LLP)は世界の多様なマクロおよびマイクロ経済の動向を継続的に調査しています。 ... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る